Difference between revisions of "Team:TecCEM/Improve"

m
Line 1: Line 1:
 
{{TecCEM}}
 
{{TecCEM}}
 
<html>
 
<html>
 +
<style>
 +
    table.table thead tr th {
 +
        text-align: center;
 +
    }
 +
</style>
 +
<div id="gif-title" class="text-project">
 +
    <img src="https://static.igem.org/mediawiki/2018/a/aa/T--TecCEM--Cells.gif" alt="Cell Gif">
 +
    <h1>Attributions</h1>
 +
</div>
 +
        <div class="container">
 +
            <div class="row">
 +
                <div class="col">
 +
                    <p> </p>
 +
                    <h1>Improvement of nanoencapsulation protocol with low molecular weight chitosan and sodium tripolyphosphate (TPP)</h1>
 +
                    <p> The main objective of nanoencapsulation was to create an efficient vehicle for protein delivery. In order to obtain this,  we used the same nanoencapsulation protocol from iGEM Team Taipei 2016, and created a smaller nanoparticle with an approximate size of ~25 nm. We assessed the fact that  during encapsulation pH may need a modification to optimize the interaction between chitosan and proteins, shifting the encapsulation efficiency. A troubleshoot was applied for this protocol to work with any protein, as pH 5.5 is not a universal ideal condition.</p>
  
 +
<p>The reason behind this is that chitosan is positively charged, and proteins with low isoelectric value are better encapsulated at a pH greater than the pI value, favoring the interaction between negatively charged proteins and chitosan. Therefore, before encapsulating any protein, the pI has to be consulted to adjust the chitosan solution pH, so that pI < pH < 6.5 (Gan and Wang, 2007).</p>
  
 +
<p>The red fluorescent protein has an isoelectric point of 4.07 and has a neutral charge when the medium pH is 4. When doing the characterization of RFP encapsulation, this was made under the next conditions: pH of 4 and solution concentrations of 3 mg/mL chitosan and 1 mg/mL TPP. This resulted in an encapsulation with an average size of ~25 nm.</p>
  
 +
<p>We performed a particle analysis in NanoSight NS300 to obtain the particle size distribution. A dot graph for a triplicate analysis is presented below.<p>
  
 +
<p>The particle sizes obtained from NanoSight NS300 differ from those observed by transmission electron microscopy (TEM), but we hypothesize this discrepancy is caused by particle conglomeration rather than different particle sizes. Water at pH 7.4 was the solvent in which particles were resuspended for the NS300 analysis, while samples were treated beforehand for the observation in TEM. This treatment helps to enable a clear observation of individual nanoparticles. This effect may not be reached in a polar environment like an aqueous solution.</p>
  
−
<div class="clear"></div>
+
<p>To demonstrate the possibility of modifying chitosan solution pH, an encapsulation procedure was carried out using bovine serum albumin (BSA). BSA has a pI ranging from 4.7 to 4.9. As chitosan is soluble in acidic environments while acquiring a positive net charge, by adjusting the pH to 5.5 BSA charges become negative, improving the interaction with chitosan. Encapsulation efficiency may be optimized with this adjustments. </p>
−
 
+
−
 
+
−
<div class="column full_size">
+
−
<h1>Improve</h1>
+
−
<p>For teams seeking to improve upon a previous part or project, you should document all of your work on this page. Please remember to include all part measurement and characterization data on the part page on the Registry. Please include a link to your improved part on this page.</p>
+
−
 
+
−
<h3>Gold Medal Criterion #2</h3>
+
−
<p><b>Standard Tracks:</b> Create a new part that has a functional improvement upon an existing BioBrick part. The sequences of the new and existing parts must be different. You must perform experiments with both parts to demonstrate this improvement. Document the experimental characterization on the Part's Main Page on the Registry for both the existing and new parts. Both the new and existing Main Page of each Part’s Registry entry must reference each other. Submit a sample of the new part to the Registry.
+
−
 
+
−
The existing part must NOT be from your 2018 part number range and must be different from the part documented in bronze #4.
+
−
 
+
−
<br><br>
+
−
<b>Special Tracks:</b> Improve the function of an existing iGEM project (that your current team did not originally create) and display your achievement on your wiki.</p>
+
−
 
+
  
 +
<p>The standard curve was done with Bradford assay to determine the concentrations of free protein in the supernatant after encapsulation and centrifugation.</p>
 +
            </div>
 +
        </div>
 +
    </div>
 
</div>
 
</div>
−
 
 
</html>
 
</html>
 
{{TecCEM/Footer}}
 
{{TecCEM/Footer}}

Revision as of 17:30, 16 October 2018

Cell Gif

Attributions

Improvement of nanoencapsulation protocol with low molecular weight chitosan and sodium tripolyphosphate (TPP)

The main objective of nanoencapsulation was to create an efficient vehicle for protein delivery. In order to obtain this, we used the same nanoencapsulation protocol from iGEM Team Taipei 2016, and created a smaller nanoparticle with an approximate size of ~25 nm. We assessed the fact that during encapsulation pH may need a modification to optimize the interaction between chitosan and proteins, shifting the encapsulation efficiency. A troubleshoot was applied for this protocol to work with any protein, as pH 5.5 is not a universal ideal condition.

The reason behind this is that chitosan is positively charged, and proteins with low isoelectric value are better encapsulated at a pH greater than the pI value, favoring the interaction between negatively charged proteins and chitosan. Therefore, before encapsulating any protein, the pI has to be consulted to adjust the chitosan solution pH, so that pI < pH < 6.5 (Gan and Wang, 2007).

The red fluorescent protein has an isoelectric point of 4.07 and has a neutral charge when the medium pH is 4. When doing the characterization of RFP encapsulation, this was made under the next conditions: pH of 4 and solution concentrations of 3 mg/mL chitosan and 1 mg/mL TPP. This resulted in an encapsulation with an average size of ~25 nm.

We performed a particle analysis in NanoSight NS300 to obtain the particle size distribution. A dot graph for a triplicate analysis is presented below.

The particle sizes obtained from NanoSight NS300 differ from those observed by transmission electron microscopy (TEM), but we hypothesize this discrepancy is caused by particle conglomeration rather than different particle sizes. Water at pH 7.4 was the solvent in which particles were resuspended for the NS300 analysis, while samples were treated beforehand for the observation in TEM. This treatment helps to enable a clear observation of individual nanoparticles. This effect may not be reached in a polar environment like an aqueous solution.

To demonstrate the possibility of modifying chitosan solution pH, an encapsulation procedure was carried out using bovine serum albumin (BSA). BSA has a pI ranging from 4.7 to 4.9. As chitosan is soluble in acidic environments while acquiring a positive net charge, by adjusting the pH to 5.5 BSA charges become negative, improving the interaction with chitosan. Encapsulation efficiency may be optimized with this adjustments.

The standard curve was done with Bradford assay to determine the concentrations of free protein in the supernatant after encapsulation and centrifugation.